Author: kwm107
-
New Chair of Urology Named
Prostate cancer physician-scientist Edward M. Schaeffer, MD, PhD, has been named chair of the departments of Urology at Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital.
-
Lesniak Named Chair of Neurological Surgery
Influential neurosurgical oncologist Maciej Lesniak, MD, will join Northwestern University Feinberg School of Medicine as chair of the Department of Neurological Surgery, effective November 1.
-
New Grant Will Fund HIV Screening and Intervention for At-Risk Youth
A team of researchers from Lurie Children’s, Rush University, the University of Illinois at Chicago, the University of Chicago and the Howard Brown Health Center has received funding from the National Institutes of Health to integrate substance use screening and brief intervention into the traditional community-based HIV testing environment.
-
Medical Education Day Celebrates Teaching and Scholarship
Feinberg faculty, staff and students participated in lectures, workshops and presentations during the 5th Annual Medical Education Day.
-
Implant Detects Spreading Cancer Cells Early
Northwestern Medicine scientists helped develop an implantable device that detects early breast cancer metastatic cells, a method that may enable physicians to identify cancer spreading in patients while treatments are still viable.
-
Probing Patient Beliefs About Painkiller Addiction
Emergency department patients have a range of beliefs and attitudes about the risk of becoming addicted to prescribed opioids, according to a recent study authored by a Feinberg medical student.
-
Increased Activity in Older Brains May Point to New Avenues for Treating Memory Loss
Recordings of neurons in a little-studied part of the brain associated with memory show an unexpected increase in activity in older brains, a finding that may suggest a new target for therapies to combat memory loss.
-
Clinical Trial Compares Lymphoma Regimens
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
-
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
-
Feinberg Welcomes New Director of Diversity and Inclusion
Teresa Mastin, PhD, the new Director of Diversity and Inclusion, joins Feinberg to strengthen and expand diversity and inclusion efforts across the medical school.
